US Edition
French Petition Reaches One Million to Challenge Duplomb Pesticide Law
FRANCE, JUL 21 – The petition demands repeal of the Duplomb law enabling use of acetamiprid, a pesticide harmful to bees, with over 1 million signatures sparking calls for parliamentary debate.
- France adopted the Duplomb law on July 8, allowing the reintroduction of the banned pesticide acetamiprid, mainly used by beet and hazelnut growers.
- The law reversed France’s 2018 ban on acetamiprid and faced opposition due to its proven toxicity to bees and unclear human health risks.
- In late June, several thousand demonstrators including farmers, scientists, and environmental groups rallied nationwide calling for the bill’s withdrawal.
- A 23-year-old master's student launched a petition on July 10 that surged past 1.1 million signatures by Sunday, demanding the law’s immediate repeal and a citizen-led consultation.
- Although the law is not yet in effect and petitions do not mandate repeal, the unprecedented public support may lead to a limited parliamentary debate amid warnings of risks to health and biodiversity.
172 Articles
172 Articles
Never before had a petition reached such heights: more than one million signatures against the Duplomb law, thanks to the initiative of Eléonore Pattery, 23.
Launched by an online student on July 10th, she went around the country. Concern for acetamiprid, neonicotinoid that has heavy health effects. And it's already a political case
The right-wing republican law Duplomb is designed to re-authorise a potentially carcinogenic pesticide and to overturn further environmental protection measures.
On Instagram, the novelist calls on the elected representatives who voted on the Duplomb Law on 8 July in the Assembly, while the petition which opposes this text exceeded one million signatures on Sunday.
This petition launched by a student, two days after the adoption of the law, provides for the reintroduction under conditions of acetamipride banned in France but authorised in Europe.
Coverage Details
Bias Distribution
- 40% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
